Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CHRISTIAN HOSPITAL NORTHEAST- NORTHWEST

NPI: 1639186760 · SAINT LOUIS, MO 63136 · Psychiatric Hospital Unit · NPI assigned 08/02/2006

$65.26M
Total Medicaid Paid
647,341
Total Claims
598,092
Beneficiaries
138
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialIROVIC, PAUL (VICE PRESIDENT, FINANCE)
NPI Enumeration Date08/02/2006

Related Entities

Other providers sharing the same authorized official: IROVIC, PAUL

ProviderCityStateTotal Paid
BARNES JEWISH HOSPITAL SAINT LOUIS MO $61.34M
BARNES JEWISH HOSPITAL SAINT LOUIS MO $56K
BARNES JEWISH HOSPITAL SAINT LOUIS MO $20K
BARNES JEWISH HOSPITAL SAINT LOUIS MO $12K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 61,139 $9.73M
2019 75,245 $14.10M
2020 61,247 $9.29M
2021 96,888 $5.40M
2022 123,389 $8.44M
2023 129,353 $10.31M
2024 100,080 $7.99M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
X4011 State-specific procedure code 34,165 31,882 $14.51M
99283 Emergency department visit for the evaluation and management, moderate severity 83,666 80,771 $14.19M
99284 Emergency department visit for the evaluation and management, high severity 35,550 33,591 $7.31M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 22,333 20,795 $6.20M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 17,962 16,841 $2.25M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 77,015 71,529 $2.20M
80053 Comprehensive metabolic panel 71,273 66,515 $1.94M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 18,781 18,397 $1.80M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 29,660 27,382 $1.47M
81001 31,339 29,860 $1.30M
Y7507 5,820 5,211 $1.18M
81025 20,407 19,651 $1.17M
71045 Radiologic examination, chest; single view 21,663 20,042 $887K
0202U Oncology (prostate), multianalyte, gene expression profiling 2,265 2,193 $763K
87631 2,266 2,232 $703K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 10,592 10,407 $557K
71046 Radiologic examination, chest; 2 views 2,836 2,730 $411K
X4006 613 526 $403K
84484 18,035 15,677 $400K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,716 1,669 $386K
74177 Computed tomography, abdomen and pelvis; with contrast material 2,006 1,898 $381K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 11,443 3,299 $360K
Y7506 1,187 1,081 $347K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 7,687 7,292 $330K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,778 1,714 $269K
83690 9,346 8,942 $257K
96375 Therapeutic injection; each additional sequential IV push 7,443 6,827 $254K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,276 1,259 $246K
70450 Computed tomography, head or brain; without contrast material 4,013 3,705 $243K
87070 792 780 $213K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 5,871 5,499 $194K
81003 8,207 7,810 $160K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2,595 2,443 $157K
87807 457 445 $129K
83880 3,723 3,491 $124K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3,946 3,480 $109K
87086 Culture, bacterial; quantitative colony count, urine 4,146 3,967 $106K
82150 1,061 1,018 $94K
X4003 1,480 1,336 $91K
96361 Intravenous infusion, hydration; each additional hour 683 623 $90K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2,892 2,782 $90K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2,821 2,716 $89K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 597 556 $79K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 1,679 707 $75K
77067 Screening mammography, bilateral, including computer-aided detection 612 608 $63K
80061 Lipid panel 5,066 4,951 $63K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 618 293 $53K
84443 Thyroid stimulating hormone (TSH) 3,679 3,573 $50K
80048 Basic metabolic panel (calcium, ionized) 837 779 $44K
83735 2,842 2,739 $44K
88305 Level IV - Surgical pathology, gross and microscopic examination 586 564 $34K
99281 Emergency department visit for the evaluation and management, self-limited or minor 518 503 $34K
85610 1,068 1,006 $24K
77063 Screening digital breast tomosynthesis, bilateral 612 608 $22K
87808 471 459 $21K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 3,277 2,837 $20K
83036 Hemoglobin; glycosylated (A1C) 2,579 2,540 $20K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 319 316 $19K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,084 919 $18K
J3490 Unclassified drugs 10,837 8,004 $17K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 804 788 $17K
84702 867 835 $17K
82077 1,551 1,412 $16K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 119 99 $11K
97161 360 330 $8K
85730 294 276 $8K
87077 327 316 $8K
62323 106 95 $7K
83605 957 873 $7K
85379 638 603 $7K
84439 955 934 $6K
45380 Colonoscopy, flexible; with biopsy, single or multiple 13 13 $6K
74019 25 25 $5K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 55 50 $5K
74176 Computed tomography, abdomen and pelvis; without contrast material 40 37 $4K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 147 146 $4K
87536 67 65 $4K
80143 274 249 $3K
90853 Group psychotherapy (other than of a multiple-family group) 157 25 $3K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 161 160 $3K
82043 498 485 $3K
80179 206 184 $3K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 75 37 $3K
71275 Computed tomographic angiography, chest, with contrast material 14 14 $2K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 76 74 $2K
87510 121 115 $2K
87480 121 115 $2K
84550 643 635 $2K
94010 31 29 $2K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 49 49 $2K
82570 464 453 $2K
87660 109 104 $2K
80050 General health panel 71 70 $2K
20610 16 12 $2K
73630 24 24 $2K
36415 Collection of venous blood by venipuncture 5,342 4,688 $2K
73564 29 26 $2K
85027 332 325 $1K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 27 26 $1K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 66 64 $1K
62368 27 26 $1K
76830 Ultrasound, transvaginal 13 12 $1K
82607 101 98 $984.43
71260 Computed tomography, thorax, diagnostic; with contrast material 16 12 $946.03
72100 106 103 $804.60
72125 Computed tomography, cervical spine; without contrast material 17 14 $718.45
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test 28 27 $651.24
73610 12 12 $595.83
87040 41 39 $479.98
73030 14 12 $462.92
86706 45 45 $397.47
88342 13 12 $381.43
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 30 29 $361.00
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 12 12 $330.96
86704 31 31 $301.64
82550 54 51 $277.72
87340 29 29 $239.50
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 79 78 $187.50
86300 12 12 $183.04
G0103 Prostate cancer screening; prostate specific antigen test (psa) 13 13 $129.49
73130 14 12 $105.16
86803 12 12 $102.69
82010 12 12 $69.84
86592 16 16 $69.32
87184 12 12 $39.72
85049 12 12 $39.70
82962 12 12 $25.97
86901 15 13 $22.94
85048 12 12 $22.54
86900 15 13 $22.36
85018 12 12 $20.99
85014 12 12 $20.99
97530 Therapeutic activities, direct patient contact, each 15 minutes 18 14 $5.82
97116 27 13 $3.47
A4215 Needle, sterile, any size, each 51 48 $0.00
J1885 Injection, ketorolac tromethamine, per 15 mg 25 25 $0.00
C1755 Catheter, intraspinal 28 25 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 21 20 $0.00